Results 71 to 80 of about 26,095 (148)

Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an ad hoc expert panel. [PDF]

open access: yesHaematologica, 2022
De Stefano V   +10 more
europepmc   +1 more source

JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib. [PDF]

open access: yesBr J Haematol
Ceccardi A   +17 more
europepmc   +1 more source

Correction: Colomba et al. Haemodynamic Forces: Emerging Markers of Ventricular Remodelling in Multiple Myeloma Cardiovascular Baseline Risk Assessment. Cancers 2024, 16, 3081. [PDF]

open access: yesCancers (Basel)
Colomba A   +13 more
europepmc   +1 more source

Mismatch Between Preclinical Cardio-Oncology and Clinical Oncology Research. [PDF]

open access: yesJACC CardioOncol
Cagnazzo R   +6 more
europepmc   +1 more source

Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma. [PDF]

open access: yesFront Oncol, 2022
Bonello F   +14 more
europepmc   +1 more source

New Strategies for the Treatment of Older Myeloma Patients. [PDF]

open access: yesCancers (Basel), 2023
Larocca A   +4 more
europepmc   +1 more source

The Emerging Role of Left Atrial Strain in Cardiovascular Risk Stratification for Multiple Myeloma Patients Undergoing Carfilzomib Therapy. [PDF]

open access: yesCancers (Basel)
Colomba A   +13 more
europepmc   +1 more source

Hyperinflammatory Syndrome as a Cardiac Injury Mechanism. [PDF]

open access: yesArq Bras Cardiol, 2021
Ayub-Ferreira SM, Lira MTSS.
europepmc   +1 more source

Home - About - Disclaimer - Privacy